Indications and uses
for prevention and treatment of these symptoms associated with motion sickness: nausea vomiting dizziness
for prevention and treatment of these symptoms associated with motion sickness: nausea vomiting dizziness
do not take more than directed to prevent motion sickness, the first dose should be taken 1/2 to 1 hour before starting activity to prevent or treat motion sickness, see below: adults and children 12 years and over take 1 to 2 tablets every 4-6 hours do not take more than 8 tablets in 24 hours, or as directed by a doctor children 6 to under 12 years give 1/2 to 1 tablet every 6-8 hours do not give more than 3 tabl...
each tablet contains: calcium 35 mg TAMPER EVIDENT: DO NOT USE IF OUTER PACKAGE IS OPENED OR BLISTER IS TORN OR BROKEN store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F) protect from moisture see end flap for expiration date and lot number
Dimenhydrinate 50 mg
Antiemetic
for prevention and treatment of these symptoms associated with motion sickness:
for children under 2 years of age unless directed by a doctor.
taking sedatives or tranquilizers.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
| adults and children 12 years and over |
|
| children 6 to under 12 years |
|
children 2 to under 6 years |
|
croscarmellose sodium, dibasic calcium phosphate dihydrate, magnesium stearate, microcrystalline cellulose, silicon dioxide, stearic acid
1-800-426-9391
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0096295145588 | GTIN-13: 0096295145588 EAN-13: 0096295145588 GTIN-12: 096295145588 UPC-A: 096295145588 GTIN storage (14 digits): 00096295145588 | leader-44-198-1.jpg |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0e2e0f88-b076-afe1-4bdd-32bca4375bec | Product name | 3 | 20250127 |
| 3e48c9c4-918d-5d23-2f0b-d2398b06be54 | Product name | 1 | 20140508 |
| 865c72dd-0d94-daac-f728-ddd4ded2a79e | Product name | 1 | 20140508 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 70000-0749 | 70000-0749-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DIMENHYDRINATE | JB937PER5C | ACTIB |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | O7TSZ97GEP | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 1 | 2025-12-05 | full-release | 2026-06-01 01:20:24 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Motion Sickness Relief | DIMENHYDRINATE | Cardinal Health 110, LLC. DBA Leader | ce83a868-bdd8-4c77-9bc0-664133028f75 | 2026-08-06 | Warnings | 70000-0749-1 70000-0749 70000074901 1546e47f-f0fa-4c0f-ad78-ba8ff09be45a ce83a868-bdd8-4c77-9bc0-664133028f75 |
Adverse event summaries are temporarily unavailable. Other product information remains available.